Add to ORKGThis Comment will address the conflict between the U.S. patent laws and biotechnology by focusing on the NIH patent application. The first part of this Comment discusses the objectives and statutory requirements of the patent system, which the NIH application purportedly did not meet. Next, this Comment focuses on the debate between NIH and its detractors. It explains NIH\u27s reasons for its actions and discusses the criticisms leveled at the agency. Finally, this Comment presents solutions to the problems that have been uncovered by this debate regarding the patentability of genes
As nearly everyone in biotechnology knows by now, the U.S. Government\u27s application for a patent ...
Just as the development of technology is a branch of the history of political and economy, so is th...
The patenting of human genes has been the focus of intense policy debate. The concerns associated wi...
This article will use the NIH patent controversy as a focal point for considering when the results o...
A revolution in genetics has been occurring since Watson and Crick discovered the structure of the d...
The various research efforts that comprise the Human Genome Project will inevitably both draw on and...
Professor Eisenberg argues against a system providing for federally-sponsored inventions to be paten...
The increasing promise of federal funding for mapping and sequencing the human genome has brought wi...
Patents on human genetic information have been controversial among different groups for different re...
The debate over human gene patents was recently reignited by New York federal Judge Robert Sweet, wh...
The controversy over human gene patents was reignited in March 2010 when a US Federal District Court...
As public and private sector initiatives race to complete the sequence of the human genome, patent i...
This comment proposes a totality-of-the-circumstances approach to analyzing biological molecules und...
There is significant domestic and international opposition to gene patents based on the fact that ge...
This editorial examines the logical structure of the United States Supreme Court decision in Myriad ...
As nearly everyone in biotechnology knows by now, the U.S. Government\u27s application for a patent ...
Just as the development of technology is a branch of the history of political and economy, so is th...
The patenting of human genes has been the focus of intense policy debate. The concerns associated wi...
This article will use the NIH patent controversy as a focal point for considering when the results o...
A revolution in genetics has been occurring since Watson and Crick discovered the structure of the d...
The various research efforts that comprise the Human Genome Project will inevitably both draw on and...
Professor Eisenberg argues against a system providing for federally-sponsored inventions to be paten...
The increasing promise of federal funding for mapping and sequencing the human genome has brought wi...
Patents on human genetic information have been controversial among different groups for different re...
The debate over human gene patents was recently reignited by New York federal Judge Robert Sweet, wh...
The controversy over human gene patents was reignited in March 2010 when a US Federal District Court...
As public and private sector initiatives race to complete the sequence of the human genome, patent i...
This comment proposes a totality-of-the-circumstances approach to analyzing biological molecules und...
There is significant domestic and international opposition to gene patents based on the fact that ge...
This editorial examines the logical structure of the United States Supreme Court decision in Myriad ...
As nearly everyone in biotechnology knows by now, the U.S. Government\u27s application for a patent ...
Just as the development of technology is a branch of the history of political and economy, so is th...
The patenting of human genes has been the focus of intense policy debate. The concerns associated wi...